Endogenous bone morphogenetic protein 2 plays a role in vascular smooth muscle cell calcification induced by interleukin 6 in vitro
Open Access
- 30 January 2017
- journal article
- research article
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 30 (3), 227-237
- https://doi.org/10.1177/0394632016689571
Abstract
Systemic inflammation is involved in vascular calcification and cardiovascular disease which is the leading cause of mortality in rheumatoid arthritis (RA). A high level of serum interleukin (IL)-6 plays a key role in local and systemic inflammation in RA. However, the underlying mechanisms remain unclear. We established a human umbilical artery smooth muscle cell (HUASMC) culturing method to investigate the possible role of IL-6 on vascular calcification. HUASMCs were obtained from umbilical arteries of healthy neonates. To detect calcification effects, HUASMCs were treated with (experimental group) or without (control group) recombinant human (rh) IL-6. The calcium deposition stain and calcium concentrations were measured, as well as the mRNA and protein levels of the regulating factor of osteogenic differentiation-bone morphogenetic protein (BMP) 2 and those calcifying related molecules including bone-specific alkaline phosphatase (BAP), osteoprotegerin (OPG), and osteopontin (OPN). Our study showed that rhIL-6 induced calcification of HUASMCs in a time- and dose-dependent manner, and upregulated expressions of BMP2, BAP, OPG, and OPN of HUASMCs. We then used the anti-BMP2 siRNA to knockdown the expression of endogenous BMP2 to confirm its role. HUASMCs were transfected with negative siRNA (control group) or the valid anti-BMP2 siRNA (experimental group) before they were treated with rhIL-6. Cells transfected with negative siRNA without IL-6 stimulating served as the blank group. The results showed that anti-BMP2 siRNA markedly decreased expressions of BMP2, BAP, OPG, and OPN, and also partly reduced the calcification of HUASMCs induced by rhIL-6. Collectively, according to our study, rhIL-6 could induce the extracellular calcification and osteogenic differentiation of human artery smooth muscle cells through upregulating endogenous BMP2 in vitro. This may be one of the underlying mechanisms of the overwhelming vascular calcification in RA.Keywords
Funding Information
- Science and Technology Department of Shandong Province Fund (2013GHY11504)
- National Natural Science Foundation of China (30370653)
This publication has 44 references indexed in Scilit:
- The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle CellsPLOS ONE, 2011
- Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcificationExperimental Gerontology, 2009
- Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritisArthritis Care & Research, 2009
- Vascular CalcificationJournal of the American Society of Nephrology, 2009
- Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of AtherosclerosisArthritis Research & Therapy, 2009
- BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cellsAtherosclerosis, 2008
- Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcificationJournal of Internal Medicine, 2006
- Cardiovascular death in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2005
- Multilineage Potential of Cells From the Artery WallCirculation, 2003
- Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart FailureCirculation, 2003